英文名稱 Anti-CD44v4

中文名稱 CD44V4抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來(lái)源 Rabbit

交叉反應(yīng) Human, Mouse, Dog, Horse, Rabbit

產(chǎn)品類型 一抗

研究領(lǐng)域 腫瘤 細(xì)胞生物 細(xì)胞膜受體 細(xì)胞表面分子 糖蛋白 內(nèi)皮細(xì)胞

蛋白分子量 predicted molecular weight: 37kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanCD44v4

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應(yīng)用 ELISA=1:500-2000 IP=1:20-100 IHC-P=1:100-500IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 CD44 antigen; CD44 molecule; Heparan sulfateproteoglycan; PGP1; CDW44; CSPG8; ECMR-III; HCELL; HUTCH-I; IN; LHR; MC56;MDU2; MDU3; MGC10468; MIC4; Pgp1; CD44 antigen isoform 4 precursor;hematopoietic cell E- and L-selectin ligand; chondroitin sulfate proteoglycan8; cell surface glycoprotein CD44; GP90 lymphocyte homing/adhesion receptor;heparan sulfate proteoglycan; hyaluronate receptor; Hermes antigen; CD44antigen; homing function and Indian blood group system; epican; phagocyticglycoprotein 1; extracellular matrix receptor III.